Curaleaf Holdings (CURLF) Net Cash Flow (2019 - 2024)

Curaleaf Holdings (CURLF) posted quarterly Net Cash Flow of $15.5 million for Q4 2024, up 165.12% year-on-year from $5.9 million in Q1 2024, and up 537.11% on a QoQ basis from $2.4 million in Q3 2024.

Curaleaf Holdings (CURLF) Net Cash Flow (2019 - 2024) Analysis & Trends

Curaleaf Holdings (CURLF) has reported Net Cash Flow for 6 consecutive years, with $15.5 million the latest figure, recorded in Q4 2024.

  • Quarterly Net Cash Flow rose 165.12% year-over-year to $15.5 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $15.5 million (up 165.56% YoY) and the FY2025 annual result came in at -$6.1 million, down 139.05% from the prior year.
  • Net Cash Flow advanced to $15.5 million in Q4 2024 per CURLF's latest filing, from $2.4 million in the prior quarter.
  • Over the last five years, Net Cash Flow for CURLF reached as high as $47.4 billion in Q2 2023 and fell as low as -$47.5 billion in Q1 2023.
  • A 5-year average of $7.4 million and a median of -$2.1 million in 2020 frame the typical range for Net Cash Flow.
  • The largest YoY upside for Net Cash Flow was 90231.44% in 2023 against a maximum downside of 84894.18% in 2023.
  • Year by year, Net Cash Flow stood at -$4.1 million in 2020, then tumbled by 355.73% to -$18.7 million in 2021, then jumped by 280.6% to $33.8 million in 2022, then plunged by 170.59% to -$23.9 million in 2023, then jumped by 165.12% to $15.5 million in 2024.
  • According to Business Quant data, Net Cash Flow over the past three periods registered $15.5 million, $2.4 million, and -$41.9 billion for Q4 2024, Q3 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 202.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -526.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 711.50 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -277.40 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 461.90 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -446.50 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -112.00 Mn
10 Curaleaf Holdings 7.13 Bn 7.13 Bn 157.29 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 15.54 Mn
Dec 31, 2024 15.54 Mn
Sep 30, 2024 2.44 Mn
Sep 30, 2024 2.44 Mn
Jun 30, 2024 -41.93 Bn
Jun 30, 2024 -41.93 Bn
Mar 31, 2024 41.93 Bn
Mar 31, 2024 41.93 Bn
Dec 31, 2023 -23.86 Mn
Dec 31, 2023 -23.86 Mn
Sep 30, 2023 31.71 Mn
Sep 30, 2023 31.71 Mn
Jun 30, 2023 47.40 Bn
Jun 30, 2023 47.40 Bn
Mar 31, 2023 -47.48 Bn
Mar 31, 2023 -47.48 Bn
Dec 31, 2022 33.80 Mn
Dec 31, 2022 33.80 Mn
Sep 30, 2022 -26.01 Mn
Sep 30, 2022 -26.01 Mn